Tofacitinib for treating active ankylosing spondylitis
Technology appraisal guidance
Reference number: TA920
Published:
This appraisal is temporarily paused subject to ongoing commercial discussions with the manufacturer. These discussion are expected to be concluded in Q4 2022.